|
Home : Unsafe Drugs : Avandia : News Articles : Article > Unpublished data undermine systematic reviews, say Cochrane researchers Article > Unpublished data undermine systematic reviews, say Cochrane researchers
that can only be achieved at present through legal action (as in the case of GlaxoSmithKline's diabetes drug Avandia (rosiglitazone), they say. “Ideally, regulators would make full clinical study reports publicly available once a regulatory decision is reached,†the Cochrane group ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




